FDA explores competency-based path for generative AI-enabled medical devices
The FDA is seeking input on a regulatory framework for medical devices that use generative AI, and is floating a competency-based path. The idea fits the lifecycle approach used for AI-based clinical decision support (CDS) and software as a medical device (SaMD).
Who is affected and how
- medtech company
- Should comment on the framework and prepare for stricter evidence of intended use and clinical risk.
- health IT
- Must align generative AI CDS development with the lifecycle-based approach.
- health policy
- Should follow how the competency-based approach, modelled on the way physicians are assessed, develops.
Sources
- Regulating AI Like a Doctor: FDA Floats Competency-Based Path for Generative AI-Enabled Devicescooley · Sep 28, 2026
- FDA Lists More Than 1,600 AI-Enabled Medical Devicesaimedicinenow.com · Sep 28, 2026
- What 1,614 FDA Authorizations Reveal About AI-Enabled Medical Devicessequenex.com · Oct 1, 2026
- FDA Seeks Input on Regulatory Framework for Generative AI-Enabled Medical Devices | Gardner Law - JDSuprajdsupra.com · Sep 29, 2026
- FDA Develops Regulatory Blueprint for Generative AI-Enabled Devices | News | Haynes Boonehaynesboone.com · Oct 2, 2026
- FDA explores generative AI medical devices | Mills & Reevemills-reeve.com · Oct 2, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.